Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Accumulated Expenses: 2024-2025

Historic Accumulated Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $8.0 million.

  • Pyxis Oncology's Accumulated Expenses fell 43.12% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 43.12%. This contributed to the annual value of $11.4 million for FY2024, which is N/A change from last year.
  • Per Pyxis Oncology's latest filing, its Accumulated Expenses stood at $8.0 million for Q3 2025, which was up 19.38% from $6.7 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Accumulated Expenses high stood at $14.1 million for Q3 2024, and its period low was $6.7 million during Q2 2025.
  • Its 2-year average for Accumulated Expenses is $10.2 million, with a median of $10.1 million in 2024.
  • Data for Pyxis Oncology's Accumulated Expenses shows a maximum YoY tumbled of 43.12% (in 2025) over the last 5 years.
  • Pyxis Oncology's Accumulated Expenses (Quarterly) stood at $11.4 million in 2024, then tumbled by 43.12% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $6.7 million for Q2 2025, and $10.1 million during Q1 2025.